Executive pay
Inhibikase Therapeutics (IKT) executive compensation
What Inhibikase Therapeutics, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.
- 2026 proxy statement
Mark Iwicki paid $30.6M.
Filed Apr 30, 2026